Trials / Completed
CompletedNCT03598491
Feasibility of a Water-soluble Contrast Application Into Dysphagia Evaluation
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 755 (actual)
- Sponsor
- Ulsan University Hospital · Academic / Other
- Sex
- All
- Age
- 3 Years
- Healthy volunteers
- Not accepted
Summary
In traditional video-fluoroscopic-swallowing study, a lipid-soluble contrast (barium sulfate) has been used more than 30 years. However, it can cause chemical pneumonitis and subsequently impair reliability of video-fluoroscopic-swallowing study if aspirated. The authors reviewed the safety and usefulness of an water soluble agent-based swallowing test.
Detailed description
Parallel-group, case-controlled trial was conducted from September 2015 to November 2017. All the patients who referred for video-fluoroscopic-swallowing study were screened. Based on the pre-emptive evaluation, high-risky patients were allocated to iohexol (Omnipaque)-used video-fluoroscopic-swallowing study and others were allocated to barium sulfate-used video-fluoroscopic-swallowing study. Statistical Package for the Social Sciences 24 was used to perform statistical analysis for the data. Quantitative data were presented as mean ± standard errors.
Conditions
Timeline
- Start date
- 2015-09-18
- Primary completion
- 2017-11-17
- Completion
- 2017-12-31
- First posted
- 2018-07-26
- Last updated
- 2019-09-27
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03598491. Inclusion in this directory is not an endorsement.